tm logo
SIMLANDI (ADALIMUMAB-XXXX) INJECTION
Live/Pending
FOURTH EXTENSION - GRANTED

granted

on 13 Mar 2024

Last Applicant/ Owned by

400 Interpace Parkway

Parsippany

NJ

07054

Serial Number

90879588 filed on 12th Aug 2021

Registration Number

N/A

Correspondent Address

Laurence Rickles

TEVA PHARMACEUTICALS USA, INC.

400 INTERPACE PARKWAY

BUILDING A

PARSIPPANY,NJ 07054

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"(ADALIMUMAB-XXXX) INJECTION"

SIMLANDI (ADALIMUMAB-XXXX) INJECTION

"(ADALIMUMAB-XXXX) INJECTION" Injectors for medical purposes, namely, medical fluid injectors The color(s) sky blue, burgundy and black is/are claimed as a feature of the mark. Pharmaceutical preparations featuring monoclonal antibodies for the treatment of autoimmune diseases The mark consists of two stylized rhombus designs, the left is sky blue and the right is burgundy. To the right of the Read More

Classification Information


Class [010]
Medical Instrument Products


Injectors for medical purposes, namely, medical fluid injectors

Class [005]
Pharmaceutical Products


Pharmaceutical preparations featuring monoclonal antibodies for the treatment of autoimmune diseases

Mark Details


Serial Number

No 90879588

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.07.13 -

Two diamonds

26.07.21 -

Diamonds that are completely or partially shaded

Description of Design Search

The mark consists of two stylized rhombus designs, the left is sky blue and the right is burgundy. To the right of the stylized rhombus designs appears the wording "SIMLANDI" written in burgundy stylized text. Beneath the wording "SIMLANDI" appears the wording "(ADALIMUMAB-XXXX)" written in black stylized font. Beneath the wording "(ADALIMUMAB-XXXX)" appears the wording "INJECTION" written in black stylized font.

Legal History


Show more

Status DateAction Taken
14th Mar 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
13th Mar 2024SOU TEAS EXTENSION RECEIVED
13th Mar 2024SOU EXTENSION 4 FILED
13th Mar 2024SOU EXTENSION 4 GRANTED
14th Sep 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12th Sep 2023SOU TEAS EXTENSION RECEIVED
12th Sep 2023SOU EXTENSION 3 FILED
12th Sep 2023SOU EXTENSION 3 GRANTED
08th Mar 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06th Mar 2023SOU TEAS EXTENSION RECEIVED